Funding and Training
CGH helps reduce the global burden of cancer by strengthening research capacity through funding and training. Below you will find the most recent funding opportunities that are relevant to our work.
CRDF Global is accepting Letters of Intent (LOIs) from early career African based investigators working in the field of cancer research for the Beginning Investigator Grant for Catalytic Research (BIG Cat) program, an African Organisation for Research and Training in Cancer (AORTIC) program with support from the U.S. National Institutes of Health’s (NIH) National Cancer Institute (NCI). The primary goals and objectives of the initiative are to support exploratory data collection by African clinicians and scientists engaged in cancer research in Africa, and to encourage research that span the cancer continuum and aimed at forming a basis for reducing the burden of cancer in Africa. Research areas can include descriptive epidemiology, prevention, detection, diagnosis, and treatment including supportive and palliative care and behavioral.
Letter of Intent Due Date: January 25, 2016
The National Cancer Institute and the National Institute of Biomedical Imaging and Bioengineering have developed a funding opportunity to support the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost devices or assays that are clinically comparable to currently used technologies for imaging, in vitro detection/diagnosis, prevention or treatment of cancers in humans living in LMICs.
Application Due Date: February 9, 2016
For more information on this initiative, please read Technologies for Global Health RFA FAQs.
The National Cancer Institute, through its Center for Global Health, seeks to facilitate the planning and design of Regional Centers of Research Excellence (RCRE) for non-communicable disease, including cancer, in low and middle-income countries (LMICs). Activities in this P20 will be implemented through collaborative partnerships between investigators from institutions in high-income countries or upper- middle-income countries and investigators, research administrators, and other stakeholders from LMICs. The planning efforts must demonstrate an understanding of the region's research capabilities and a commitment to enhance these capabilities with a focus on basic, translational, clinical, and population science research for Non-Communicable Diseases (NCDs). Research activities undertaken through this initiative should demonstrate that the collaborators can work together to answer NCD questions that are relevant, timely, and important to the concerned region.
The planning efforts to be supported under this FOA should initiate Regional Centers of Research Excellence on NCDs, and demonstrate an ability to undertake high-quality, well-coordinated, regionally-relevant collaborative research on NCDs in LMICs.
For more information, please view our Frequently Asked Questions (FAQ) page. We will be updating the FAQ site continually, so please check back regularly to view new FAQs.
The attached short slide set is included to clarify the intent and mechanics of the RFA.
Open Date: September 14, 2015
Application Due Date: December 10, 2015 and August 3, 2016
The National Cancer Institute, through its Center for Global Health, Division of Cancer Control and Population Sciences, Division of Cancer Treatment and Diagnosis, and National Institute of Biomedical Imaging and Bioengineering, invites applications from research partnerships formed between scientists from U.S. and Turkey to accelerate the development of appropriate affordable diagnostic and therapeutic technologies, which address medical needs in low-middle resource settings. The collaborations should be aimed at developing medical technologies that can significantly impact underserved populations within the United States and/or Turkey, and potentially populations in Low and Middle Income Countries, particularly in Africa, the Middle East, Eastern Europe, and Latin America.
Open Date: September 5, 2015
Application Due Date: October 8, 2015, by 5:00 PM local time of applicant organization
The National Cancer Institute (NCI), through its Center for Global Health (CGH), seeks to promote cancer prevention and control (CPC) research in low- and middle-income countries (LMICs) through collaborations and research partnerships between the NCI-designated cancer centers and partner institutions in LMICs. Through this funding opportunity announcement (FOA), the NCI will provide administrative supplement awards to currently-funded P30 NCI-designated cancer center grantees to support pilot research plans that focus on cancer prevention and control. These supplements are designed to stimulate and strengthen CPC twinning programs between researchers at the NCI-designated cancer centers and institutions in LMICs. It is anticipated that outcomes of this supplement will include collaborative research grants between investigators at the NCI-designated cancer centers and LMIC institutions.
Open Date: May 8, 2015
Application Due Date: Closed
The National Cancer Institute, Division of Cancer Treatment and Diagnosis has developed a funding opportunity to encourage applications from research partnerships formed by academic and industrial investigators, to accelerate the translation of technologies, methods, assays or devices, and/or systems for pre-clinical or clinical molecular diagnosis or in vitro imaging that are designed to solve a targeted cancer problem.
Application Due Date: Closed
CGH and the Caribbean Public Health Agency (CARPHA) have developed a co-funded opportunity to support the research of cancers that are of a significant burden within a Caribbean population or community, a Caribbean country, or throughout the Caribbean.
Application Due Date: Closed
Scientific Review: January 31, 2015
The STSEP promotes collaborative research between established U.S. and foreign scientists from low- and middle-income countries (LMICs) and upper-middle income countries by supporting, in part, exchange visits of cancer researchers between U.S. and foreign laboratories that are six months or less.
This program offers two short-term cancer prevention training courses in Rockville, MD to international scientists and healthcare professionals from LMICs, the International Atomic Energy Agency’s Programme of Action for Cancer Therapy (IAEA-PACT), and the All-Ireland Cancer Consortium (AICC).